Individualized FSH dosing improves safety and reduces iatrogenic poor response while maintaining live-birth rates

Hum Reprod. 2018 May 1;33(5):982-983. doi: 10.1093/humrep/dey061.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Birth Rate*
  • Fertilization in Vitro
  • Follicle Stimulating Hormone
  • Humans
  • Iatrogenic Disease*
  • Live Birth
  • Ovulation Induction
  • Pregnancy Rate

Substances

  • Follicle Stimulating Hormone